Founder & CEO
Akron Biotechnology
Claudia Zylberberg, Ph.D., is a leader in regenerative medicine. She is the founder and CEO of Akron Biotechnology, a leading developer and manufacturer of cGMP-grade ancillary materials and a purveyor of specialized services to cell and gene therapy developers, contract development and manufacturing organizations, and tissue engineering companies, among others. Under Dr. Zylberberg’s leadership, Akron has received grants from the Department of Defense (DoD) and the National Institutes of Health (NIH), as well as two Manufacturing USA Institutes, the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) and the Advanced Regenerative Manufacturing Institute (ARMI). She also co-founded AssureImmune, an adult stem cell bank. Dr. Zylberberg has developed various patented and patent-pending technologies, including cryopreservation media, oligonucleotides, and recombinant protein formulations, and has coauthored numerous academic articles in high-impact publications.
Dr. Zylberberg has engaged in several multi-stakeholder initiatives to formalize and strengthen the regenerative medicine industry. She co-founded the Standards Coordinating Body (SCB) and has supported the development of critical standards promoted by International Organization for Standardization (ISO). She holds advisory positions at the International Society for Cellular Therapy (ISCT), the Alliance for Regenerative Medicine (ARM) Foundation, the Florida Organization for Regenerative Medicine (FORM), and the National Academy of Science’s (NAS) Regenerative Medicine Forum, among others.
